Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure.

[1]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[2]  C. Frampton,et al.  B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction , 2003, Circulation.

[3]  Y. Kagaya,et al.  Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[4]  P. Varadarajan,et al.  Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. , 2003, Journal of cardiac failure.

[5]  L. Fisher,et al.  Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) , 2003, Circulation.

[6]  B. Bozkurt,et al.  Use of biomarkers in the management of heart failure: are we there yet? , 2003, Circulation.

[7]  Y. Kagaya,et al.  Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[8]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[9]  E. Antman,et al.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[11]  H. Huikuri,et al.  Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.

[12]  H. T. ter Keurs,et al.  Stretch and quick release of rat cardiac trabeculae accelerates Ca2+ waves and triggered propagated contractions. , 2001, American journal of physiology. Heart and circulatory physiology.

[13]  A. Takeshita,et al.  Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. , 2001, The American journal of cardiology.

[14]  S. Pikkarainen,et al.  Mechanical load-induced alterations in B-type natriuretic peptide gene expression. , 2001, Canadian journal of physiology and pharmacology.

[15]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[16]  J. Burnett,et al.  Natriuretic peptides in the pathophysiology of congestive heart failure , 2000, Current cardiology reports.

[17]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[18]  M. Yokoyama,et al.  Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[19]  W. Stevenson,et al.  Arrhythmias and sudden death in heart failure. , 1997, Japanese circulation journal.

[20]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[21]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[22]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[23]  C. Lang,et al.  QT dispersion and sudden unexpected death in chronic heart failure , 1994, The Lancet.

[24]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.